Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 6
2003 7
2004 5
2005 9
2006 14
2007 4
2008 4
2009 6
2010 8
2011 10
2012 10
2013 12
2014 11
2015 17
2016 14
2017 18
2018 9
2019 9
2020 13
2021 17
2022 18
2023 12
2024 9
2025 15
2026 4

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

226 results

Results by year

Filters applied: . Clear all
Page 1
Real-world management of familial hypercholesterolemia in paediatric patients: a 3-year follow-up from the LIPIGEN registry.
Galimberti F, Capra ME, Olmastroni E, Braghiroli D, Banderali G, Baratta F, Biasucci G, Biolo M, Buonuomo PS, Cefalù AB, Cipollone F, Citroni N, D'Addato S, Genovesi S, Guardamagna O, Iughetti L, Mandraffino G, Minicocci I, Mombelli GG, Montalcini T, Nascimbeni F, Passaro A, Pirro M, Rinaldi E, Sbrana F, Scicali R, Suppressa P, Werba PJ, Zenti MG, Arca M, Averna M, Tarugi P, Calandra S, Catapano AL, Pederiva C, Casula M; LIPIGEN Paediatric Group. Galimberti F, et al. Among authors: averna m. Atherosclerosis. 2026 Apr;415:120691. doi: 10.1016/j.atherosclerosis.2026.120691. Epub 2026 Feb 25. Atherosclerosis. 2026. PMID: 41764820 Free article.
Sustainable and Effective Lipid-Lowering Management: Prevention Strategies from the BRING-UP Prevention Study.
Colivicchi F, Temporelli PL, Fattirolli F, Abrignani MG, Alonzo A, Arca M, Averna M, Bertoli D, Calabrò P, Calò L, Carugo S, Catapano AL, Ceseri M, Di Fusco SA, Di Lenarda A, Fabbri G, Gulizia MM, La Rosa G, Lucci D, Maffei S, Navazio A, Oliva F, Orso F, Riccio C, Scelza N, Gabrielli D, Maggioni AP; BRING-UP Prevention. Colivicchi F, et al. Among authors: averna m. Eur Heart J Qual Care Clin Outcomes. 2026 Feb 8:qcag021. doi: 10.1093/ehjqcco/qcag021. Online ahead of print. Eur Heart J Qual Care Clin Outcomes. 2026. PMID: 41655227
Long-term efficacy and safety of lomitapide in patients with familial chylomicronemia syndrome: Data from an expanded access program.
Giammanco A, D'Erasmo L, Iannuzzo G, Noto D, Montali A, Zambon A, Forte F, Suppressa P, Giannini S, Barbagallo CM, Gagliardo CM, Nardi E, Tramontano D, Brancatelli G, Arca M, Cefalù AB, Averna M. Giammanco A, et al. Among authors: averna m. J Clin Lipidol. 2026 Jan;20(1):104-111. doi: 10.1016/j.jacl.2025.10.073. Epub 2025 Nov 3. J Clin Lipidol. 2026. PMID: 41330803 Free article. Clinical Trial.
Contemporary Management of Familial and Multifactorial Chylomicronemia Syndromes in Italy: Insights From the National LIPIGEN Registry.
D'Erasmo L, Tramontano D, Di Costanzo A, Casula M, Galimberti F, Baratta F, Cefalù AB, Tarugi PM, Calandra S, Zambon A, Averna M, Catapano AL, Arca M; LIPIGEN-sHTG Group. D'Erasmo L, et al. Among authors: averna m. Arterioscler Thromb Vasc Biol. 2025 Dec;45(12):2264-2276. doi: 10.1161/ATVBAHA.125.323340. Epub 2025 Oct 16. Arterioscler Thromb Vasc Biol. 2025. PMID: 41099101 Free PMC article.
Consensus document on the role of plasma triglycerides in cardiovascular disease from the Italian Society for the Study of Atherosclerosis (SISA).
Zambon A, Gentile L, Galimberti F, Manzato E, Giaccari A, Sesti G, Belfiore A, Norata GD, Temporelli PL, Frulloni L, Bucci M, Poli A, Arca M, Averna M, Catapano AL. Zambon A, et al. Among authors: averna m. Nutr Metab Cardiovasc Dis. 2025 Dec;35(12):104214. doi: 10.1016/j.numecd.2025.104214. Epub 2025 Jun 28. Nutr Metab Cardiovasc Dis. 2025. PMID: 40887367
Patient experience with familial chylomicronemia syndrome before and after olezarsen treatment: Qualitative interviews with clinical trial participants.
Sikora Kessler A, Brown TM, Bratlee-Whitaker E, Fehnel S, Vera-Llonch M, Arca M, Averna M, Baass A, Baum SJ, Bergeron J, Gaudet D, Muñiz-Grijalvo O, Alexander VJ, Tsimikas S. Sikora Kessler A, et al. Among authors: averna m. J Clin Lipidol. 2025 Sep-Oct;19(5):1243-1255. doi: 10.1016/j.jacl.2025.06.014. Epub 2025 Jun 18. J Clin Lipidol. 2025. PMID: 40713231 Free article. Clinical Trial.
LDL-cholesterol levels and lipid lowering therapy in secondary prevention. Baseline data from the BRING-UP prospective registry.
Colivicchi F, Fabbri G, Oliva F, Abrignani MG, Arca M, Averna M, Catapano AL, Ceseri M, Di Fusco SA, Di Lenarda A, Fattirolli F, Gabrielli D, Gonzini L, Gulizia MM, Riccio C, Temporelli PL, Aloia A, Alonzo A, Aschieri D, Barbato E, Bertoli D, Calabrò P, Calò L, Carugo S, Crisci V, La Rosa G, Maffei S, Navazio A, Pavan D, Scelza N, Scicchitano P, Themistoclakis S, Maggioni AP; on the behalf of BRING-UP Prevention. Colivicchi F, et al. Among authors: averna m. Int J Cardiol. 2025 Aug 15;433:133290. doi: 10.1016/j.ijcard.2025.133290. Epub 2025 Apr 19. Int J Cardiol. 2025. PMID: 40258403 Free article.
[The BRING-UP Prevention study: a national participation model for the improvement of secondary prevention strategies].
Colivicchi F, Orso F, Oliva F, Abrignani MG, Arca M, Averna M, Catapano AL, Ceseri M, Di Fusco SA, Di Lenarda A, Fattirolli F, Lucci D, Gonzini L, Gulizia MM, Riccio C, Temporelli PL, Bertaina M, Cortese F, Nuzzi V, Poli S, Reccia M, Maggioni AP, Gabrielli D; a nome dei Ricercatori dello Studio BRING-UP Prevenzione. Colivicchi F, et al. Among authors: averna m. G Ital Cardiol (Rome). 2025 Jul;26(7):457-463. doi: 10.1714/4522.45218. G Ital Cardiol (Rome). 2025. PMID: 40567186 Italian. No abstract available.
226 results